Pediatrics – Endocrinology
Cohort Study | Association of assisted reproductive technology with offspring growth and adiposity from infancy to early adulthood.
1 Aug, 2022 | 11:54h | UTC
Commentary on Twitter
This cohort study found that differences in early growth and adiposity for people conceived via assisted reproductive technology (vs. naturally) were small and reduced with older age. @aelhak19 @DeborahLawlor2 https://t.co/hwdldN6yDf
— JAMA Network Open (@JAMANetworkOpen) July 26, 2022
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolemia.
18 Jul, 2022 | 11:18h | UTC
Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages.
11 Jul, 2022 | 12:10h | UTCNews Release: Study finds childhood obesity occurring at greater frequency, with more severity and at younger ages – Emory University
Original Study: Changes in the Incidence of Childhood Obesity – Pediatrics
Systematic Review: Cortisol levels during acute illnesses in children and adolescents.
24 Jun, 2022 | 10:54h | UTC
M-A: Overweight/obesity in childhood and the risk of early puberty.
21 Jun, 2022 | 10:36h | UTCRelated Study: Patterns of Early Life Weight Gain and Female Onset of Puberty – Journal of the Endocrine Society
#ADA2022 – RCT: Once-weekly dulaglutide for the treatment of youths with type 2 diabetes.
6 Jun, 2022 | 11:57h | UTCOnce-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association
Commentary on Twitter
Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe
— NEJM (@NEJM) June 4, 2022
M-A: Screen time and body mass index among children and adolescents.
3 Jun, 2022 | 11:44h | UTCRelated:
M-A: Global prevalence of meeting screen time guidelines among children 5 years and younger.
Media and Young Minds – American Academy of Pediatrics
The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases.
5 May, 2022 | 09:57h | UTCThe role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases – Nature Reviews Endocrinology (if the link is paywalled, try this one)
RCT: Phentermine/Topiramate for the treatment of adolescent obesity.
2 May, 2022 | 00:41h | UTCPhentermine/Topiramate for the Treatment of Adolescent Obesity – NEJM Evidence
Commentary on Twitter
This RCT evaluated phentermine/topiramate in adolescents ages 12 to <17 yrs with high BMIs over a 56 week period. At both mid- and top-doses, treatment significantly reduced BMI and waist circumference compared to placebo. https://t.co/HbCZOAlZPf@PedsEndoSociety #PedsEndo2022 pic.twitter.com/nB5juqxyA0
— NEJM Evidence (@NEJMEvidence) April 30, 2022
Analysis: Changing the assortment of available food and drink for leaner, greener diets.
18 Apr, 2022 | 10:39h | UTCChanging the assortment of available food and drink for leaner, greener diets – The BMJ
News Release: Changing products on offer in shops and restaurants can lead to leaner, greener diets – BMJ
Review: Management challenges and therapeutic advances in congenital adrenal hyperplasia.
18 Apr, 2022 | 10:10h | UTCManagement challenges and therapeutic advances in congenital adrenal hyperplasia – Nature Reviews Endocrinology (if the link is paywalled, try this one)
Commentary on Twitter
New content online: Management challenges and therapeutic advances in congenital adrenal hyperplasia https://t.co/RCH4mRmvYe pic.twitter.com/76Jm00ISV1
— Nature Reviews Endocrinology (@NatureRevEndo) April 11, 2022
RCT: Dapagliflozin did not significantly improve glycemic control in children and young adults with type 2 diabetes.
13 Apr, 2022 | 10:46h | UTCEfficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
M-A: Effect of obesity treatment interventions in preschool children aged 2–6 years.
11 Apr, 2022 | 00:47h | UTC
Cohort Study: Comparison of rates of Type 2 Diabetes in adults and children treated with anticonvulsant mood stabilizers.
7 Apr, 2022 | 08:32h | UTC
Commentary on Twitter
This cohort study found that the choice of which anticonvulsant mood stabilizer to initiate may have meaningful reductions in type 2 diabetes incidence; valproate was associated with the highest risk and lamotrigine the lowest. https://t.co/pyME0G25wt
— JAMA Network Open (@JAMANetworkOpen) April 6, 2022
Consensus Paper: Vitamin D and calcium intakes in general pediatric populations.
22 Mar, 2022 | 08:36h | UTC
Cohort Study: Patterns of early life weight gain and female onset of puberty.
16 Mar, 2022 | 08:46h | UTCPatterns of Early Life Weight Gain and Female Onset of Puberty – Journal of the Endocrine Society
Commentary: Early life weight gain predicts pubertal onset in girls – Healio
Study suggests banning the promotion of soft drinks could be more effective than a sugar tax.
22 Feb, 2022 | 08:25h | UTCBanning the promotion of soft drinks could be more effective than a sugar tax – The Conversation
Original Study: Industry levy versus banning promotion on soft drinks in Scotland: A distributional analysis – Food Policy
Related:
Association of a sweetened beverage tax with reduction in soda consumption in high school students.
UK National Food Strategy: Tax sugar and salt and prescribe veg, report says.
Perspective – Sugar-sweetened beverage taxes: Lessons to date and the future of taxation
Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption
Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake
Study: Snack Tax May be More Effective than a Sugary Drink Tax to Tackle Obesity
Sugar Tax: Why Health Experts Want it But Politicians and Industry are Resisting
The Effect of Food Price Changes on Consumer Purchases: A Randomized Experiment
Taxes on Sugar-Sweetened Beverages Associated with Reduced Consumption
Soda Tax Linked to a 50 Percent Reduction in Sugary Drink Consumption
Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization
The Lancet taskforce on NCDs and economics
To improve global health, tax the things that are killing us – Financial Times
Reducing cardiovascular disease burden through targeted dietary policies
Fiscal policies for the prevention of diseases
Guideline for the management of pediatric Graves’ disease.
11 Feb, 2022 | 08:24h | UTC
Podcast: Dyslipidemia in Children.
8 Feb, 2022 | 08:33h | UTC
Review: Prevention of atherosclerosis from childhood.
2 Feb, 2022 | 08:12h | UTCPrevention of atherosclerosis from childhood – Nature Reviews Cardiology (if the link is paywalled, try this one)
RCT: In very young children with Type 1 Diabetes, a hybrid closed-loop therapy (“artificial pancreas”) resulted in better glycemic control without increased risk of hypoglycemia vs. sensor-augmented pump therapy.
20 Jan, 2022 | 09:07h | UTCRandomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Association of a sweetened beverage tax with reduction in soda consumption in high school students.
26 Oct, 2021 | 01:30h | UTCAssociation of a Sweetened Beverage Tax With Soda Consumption in High School Students – JAMA Pediatrics (free for a limited period)
Related:
UK National Food Strategy: Tax sugar and salt and prescribe veg, report says.
Perspective – Sugar-sweetened beverage taxes: Lessons to date and the future of taxation
Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption
Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake
Study: Snack Tax May be More Effective than a Sugary Drink Tax to Tackle Obesity
Sugar Tax: Why Health Experts Want it But Politicians and Industry are Resisting
The Effect of Food Price Changes on Consumer Purchases: A Randomized Experiment
Taxes on Sugar-Sweetened Beverages Associated with Reduced Consumption
Soda Tax Linked to a 50 Percent Reduction in Sugary Drink Consumption
Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization
The Lancet taskforce on NCDs and economics
To improve global health, tax the things that are killing us – Financial Times
Reducing cardiovascular disease burden through targeted dietary policies
Fiscal policies for the prevention of diseases
Commentary on Twitter
Sweetened beverage consumption is higher among adolescents and young adults than any other age group. A new study at #jamapediatrics reports that sweetened beverage taxes are associated with reduced soda consumption in this group. https://t.co/UJdxpY7gl2 pic.twitter.com/aEdcUccLYW
— JAMA Pediatrics (@JAMAPediatrics) October 23, 2021
Systematic Review: “Formula milk trials have a high risk of bias, almost always report favorable conclusions, lack transparency, and selectively report findings”.
15 Oct, 2021 | 02:25h | UTCNews release: Formula milk trials are not reliable, warn researchers – Imperial College London
Original study: Conduct and reporting of formula milk trials: systematic review – The BMJ
ADA Consensus Report: The Management of Type 1 Diabetes in Adults.
3 Oct, 2021 | 22:38h | UTCRelated: Guideline: ADA 2021 Standards of Medical Care in Diabetes
Commentary on Twitter
What a fantastic symposium on the management of #T1D at #EASD2021! Read the full ADA–EASD consensus report here https://t.co/8cEm8N0Enr pic.twitter.com/uMj2R64CkK
— Diabetologia (@DiabetologiaJnl) October 1, 2021
Defining pediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.
7 Sep, 2021 | 21:26h | UTCDefining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement – The Lancet Gastroenterology & Hepatology (free registration required)
Commentary on Twitter
New Viewpoint – Eslam et al – Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementhttps://t.co/YIW0DL7u5O#NAFLD #MAFLD #fattyliver #LiverTwitter @eslamm1222 pic.twitter.com/2AIHksqIgj
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) August 6, 2021


